JMP Securities analyst Erik Suppiger reiterates Varonis Systems (NASDAQ:VRNS) with a Market Outperform and maintains $63 price target.
Ensysce Biosciences CEO Lynn Kirkpatrick Issues 2024 Shareholder Letter
Dear Fellow Shareholders,I am very pleased to provide you with an update on the outstanding progress we made over the last year and to extend sincere thanks from the Ensysce team for your ongoing support. During 2023,